Myeloma
The Royal Marsden offers a range of myeloma treatment and care services for patients at its hospitals in Chelsea, London, and Sutton, Surrey:
| Diagnosis, tests and investigations |
Primary assessment and diagnosis in partnership with other hospitals
Diagnosis and review at The Royal Marsden |
| Cancer genetics |
Yes |
| Chemotherapy |
Yes |
| Radiotherapy |
Yes |
| Other treatment |
Stem cell transplant
Total body irradiation |
| Critical care |
Yes |
| Rehabilitation |
Yes, including a pre-transplant programme |
| Palliative and supportive care |
Yes |
Services are provided through a specialised inpatient unit for the delivery of more intensive chemotherapy and a newly refurbished outpatient area
Primary assessment and diagnosis
- Full blood count
- Biochemistry
- Immunoglobulins testing
- Paraprotein testing
- Serum free light chain measurement
- Bone marrow estimation
- Skeletal surveys
- MRI
- PET CT
- Bone marrow genetics
- FISH (fluorescence in situ hybridisation)
- Cytogenetics
- Novel prognostic markers
Treatment
- Stem cell transplants (autologous and allogeneic donor transplants)
- Chemotherapy using drugs such as Thalidomide, Velcade and Revlimid
- Intensive strategies for aggressive disease
- Access to novel drugs and clinical trials
Patient care and support
- Clinical nurse specialist in myeloma
- Specialist transplant nurses
- Pain control
- Orthopaedic and renal links